Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

IBM Helps Entrepreneurs Empower Patients With Tools To Improve Personal Health

May 18, 2011 8:38 am | by IBM | News | Comments

IBM (NYSE: IBM) is working closely with a group of entrepreneurs whose new technologies can transform how people manage their personal health, the company said today at its SmartCamp in Austin, Texas. The forum there, one of several the company will do this year, is part of its investment...

Ever Play 20 Questions with a Referring Physician?

May 18, 2011 8:38 am | by Diagnostic Imaging | News | Comments

At least one radiologist is tired of ED physicians asking 20 questions after every scan. Do you share his pain?

Celldex prices $31.5M stock offering

May 18, 2011 6:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Celldex Therapeutics Inc., the Needham company developing a brain cancer vaccine, has priced a public offering of 10 million shares of its common stock at about $3.15 per share. The offering would raise $31.5 million, with Celldex taking in about $29.4 million in net proceeds.

Advertisement

FluoroPharma Announces Completion of Merger and Fund Raising

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 18, 2011 /- FluoroPharma Medical (OTC.BB: CEWM) announced that it has completed a merger transaction with Commercial E Waste Management (CEWM). Effective as of the closing of the transaction, FluoroPharma became a wholly-owned subsidiary of CEWM. The newly combined, publicly...

PLC Medical Systems Adds Vice President of Clinical Affairs

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it has named Susan Papalia, RN, BSN, Vice President of Clinical Affairs.  In her new role, she will be responsible for overseeing and...

Draft Guidance for Industry and Food and Drug Administration Staff - Class II Special Controls Guidance Document: In Vitro Diagnostic Devices for Bacillus spp. Detection

May 18, 2011 6:31 am | by U.S. Food & Drug Administration | News | Comments

This draft special controls guidance document was developed to support the proposed classification of in vitro diagnostic device for Bacillus spp. detection, a previously unclassified type of preamendments device, into class II, as recommended by the...

Cepheid Appoints LABSCO as US Small Hospital Distributor

May 18, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., May 18, 2011 /- Cepheid (NASDAQ: CPHD ) today announced it has entered into an agreement with LABSCO ( www.labsco.com ), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid's GeneXpert®...

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011 4:33 am | by Boston Scientific | News | Comments

Results for Boston Scientific WATCHMAN device presented at EuroPCR

Advertisement

Reportlinker Adds Hong Kong SMBG Devices and Strips Market

May 18, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 18, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hong Kong SMBG Devices and Strips Market...

Shire buys Advanced BioHealing for $750M

May 17, 2011 2:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Advanced BioHealing Inc., the Connecticut biotech that filed for a $200 million IPO at the beginning of May, has been scooped up before its IPO for $750 million cash by Shire plc, the Irish company with its Human Genetic Therapies business presence in Lexington.

University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center

May 17, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

CLEVELAND, May 17, 2011 /- University Hospitals Seidman Cancer Center announced plans to establish a $30 million proton therapy center, becoming one of an elite group of cancer centers in the country to offer this revolutionary technology. Proton therapy is an advanced type of radiation...

Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting

May 17, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., May 17, 2011 /- VIVUS, Inc. (NASDAQ: VVUS ) today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) were...

Allina Hospitals & Clinics to Save on Commodity Supply Purchases Through Novation's New Committed Portfolio

May 17, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

IRVING, Texas, May 17, 2011 /- Allina Hospitals & Clinics, which serves patients throughout Minnesota and western Wisconsin, has simplified its commodity supply management strategies with the help of VHA Inc, the national health care network and Novation, VHA's supply contracting...

Advertisement

U.S. Chamber Inducts PCMA President & CEO Mark Merritt to its Committee of Top Trade Assoc. Executives

May 17, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, May 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Chamber of Commerce has welcomed Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt into its elite "Association Committee of 100," which includes America's top trade association executives....

Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study

May 17, 2011 12:33 pm | by Bio-Medicine.Org | News | Comments

MADISON, N.J., May 17, 2011 /- Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold,...

CryoLife Announces Completion of Acquisition of Cardiogenesis

May 17, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, and IRVINE, Calif., May 17, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation ("Cardiogenesis"). The...

Zen Holding Corp. Signs LOI to Acquire Millennium Healthcare Solutions Inc.

May 17, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SYOSSET, N.Y., May 17, 2011 /- Zen Holding Corp. (Symbol: ZNHL) today announced the signing of a Letter of Intent to purchase 100% of Millennium Healthcare Solutions Inc. and its accompanying subsidiaries and pending patent.  Final agreements will be signed upon the completion of due...

Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations

May 17, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., May 17, 2011 /- Cynosure, Inc. (Nasdaq: CYNO ), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the receipt of two additional international clearances for the Company's new flagship workstations...

Transition of Arizant Temperature Management Products To 3M Branding Confirms Integration Is Well On Track

May 17, 2011 1:37 am | by RealWire | News | Comments

Further to the acquisition by 3M in October 2010 of Arizant Healthcare Inc., an innovator in forced-air patient warming solutions, products in the Arizant portfolio will shortly transition to 3M branding. Accompanied by subtle changes to packaging and labelling from the end of May 2011,...

Reportlinker Adds Medical Devices Reports Bundle

May 17, 2011 1:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 17, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Medical Devices Reports Bundle...

New CE Marked Prognostic Claim for the VerifyNow P2Y12 Test

May 16, 2011 11:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 17, 2011 /- Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use...

Red Hill Studios/UCSF Partnership to Showcase 'Gaming Therapy' for People With Parkinson's Disease at Games for Health Conference

May 16, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

BOSTON, May 16, 2011 /- Red Hill Studios, in partnership with the UCSF School of Nursing, will showcase a custom suite of Kinect™-based physical therapy games that have been specifically designed to help people with Parkinson's slow the progression of this neurodegenerative disease....

AACR Hosts Successful 102nd Annual Meeting in Orlando

May 16, 2011 12:32 pm | by AACR | News | Comments

Tweet PHILADELPHIA - More than 16,000 people from 67 countries around the world, including Japan, attended the American Association for Cancer Research's 102nd Annual Meeting, held in Orlando, Fla., April 2-6, 2011. “We were excited to host our Annual Meeting in Orlando, a...

AACR Invites Nominations for the 2011 AACR Distinguished Lecture on the Science of Cancer Health Disparities

May 16, 2011 12:32 pm | by AACR | News | Comments

Tweet PHILADELPHIA - The American Association for Cancer Research announces a call for nominations for the 2011 AACR Distinguished Lecture on the Science of Cancer Health Disparities, funded by Susan G. Komen for The Cure®. The lecture, established in 2010, honors an investigator whose...

AACR Congratulates Two Members on Their Election Into the National Academy of Sciences

May 16, 2011 12:32 pm | by AACR | News | Comments

Tweet   PHILADELPHIA - The American Association for Cancer Research congratulates two of its members, Ira Mellman, Ph.D., and Luis F. Parada, Ph.D., on their election to the National Academy of Sciences. “We are very proud to announce the election of these two distinguished AACR...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading